EFFECT OF THE SELECTIVE SEROTONIN REUPTAKE INHIBITOR PAROXETINE ON PLATELET FUNCTION IS MODIFIED BY A SLC6A4 SEROTONIN TRANSPORTER POLYMORPHISM